| At a glance | Progressive neurodegenerative movement disorder from nigrostriatal dopamine loss. | Bilateral, largely symmetric postural and kinetic tremor of the hands; the most common adult movement disorder. |
|---|
| Classic presentation | Asymmetric rest tremor + bradykinesia + cogwheel rigidity with excellent response to levodopa is highly suggestive.; Motor: rest tremor (typically asymmetric, 4-6 Hz 'pill-rolling'), bradykinesia (slowness initiating and executing movement), rigidity (cogwheel or lead-pipe), postural instability (later); Gait: shuffling, short steps,… | Bilateral symmetric hand tremor present with action and posture, absent at rest, often with positive family history and alcohol responsiveness.; Hand tremor with writing, drinking from a cup, eating soup, or holding a posture; Voice tremor produces a quavering quality, especially with sustained 'ahhh'; Head tremor (titubation),… |
|---|
| Workup / key labs | MDS clinical diagnostic criteria: bradykinesia plus rest tremor and/or rigidity; supported by clear levodopa response, levodopa-induced dyskinesia, rest tremor, olfactory loss; red flags suggesting atypical parkinsonism must be absent.; Largely a clinical diagnosis; labs to exclude mimics: TSH, CBC, BMP, B12; Consider ceruloplasmin in… | MDS 2018: isolated tremor syndrome of bilateral upper limb action tremor for ≥3 years, ± other locations, without other neurologic signs.; TSH to exclude hyperthyroidism; BMP and glucose if metabolic causes suspected; Ceruloplasmin if age <40 to rule out Wilson disease; Medication review for tremorogenic drugs |
|---|
| Imaging | MRI brain — usually normal in PD; helps exclude vascular disease, NPH, atypical parkinsonism; DaTscan (123I-ioflupane SPECT) — shows reduced striatal dopamine transporter binding; differentiates PD/atypical parkinsonism from essential tremor or drug-induced parkinsonism, but does NOT distinguish PD from MSA/PSP/CBD; Levodopa challenge —… | Brain imaging not routinely required — order MRI only if focal findings or atypical features; DaTscan SPECT can distinguish ET from PD when uncertain (normal in ET, abnormal in PD) |
|---|
| First-line treatment | Levodopa/carbidopa — most effective symptomatic therapy; carbidopa inhibits peripheral DOPA decarboxylase to reduce nausea and increase central availability; start low (25/100 TID) and titrate; Dopamine agonist — pramipexole, ropinirole, rotigotine (transdermal); levodopa remains the preferred initial dopaminergic therapy at any age… | Propranolol 60-320 mg/day (non-selective beta-blocker) — first-line, may need long-acting formulation; contraindicated in asthma, severe bradycardia, decompensated HF; Primidone 25-250 mg/day, titrated slowly — comparably effective to propranolol; common acute first-dose toxicity (sedation, ataxia, nausea) often abates; Combination of… |
|---|